Last year, former president Donald Trump called monoclonal antibodies a "cure" for COVID-19 and vowed to make them available for all Americans. After all, they were part of Trump's own treatment that ...
TARRYTOWN, N.Y. - A COVID-19 antibody cocktail developed by U.S. drugmaker Regeneron offered strong protection against symptomatic infection when given to people living with someone else infected with ...
TARRYTOWN, N.Y., July 20, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Regeneron's ...
TARRYTOWN, N.Y. - Regeneron Pharmaceuticals said Monday that a single dose of its antibody treatment reduced the risk of contracting COVID-19 by 81.6% for up to eight months, according to its ...
A potential treatment against the COVID-19 virus could be coming, but not in the form of another vaccine. Healthcare company Regeneron is seeking approval from the U.S. Food and Drug Administration ...
This phase 3, placebo-controlled platform trial evaluated a single infusion of casirivimab and imdevimab (REGEN-COV) at 2400-mg and 1200-mg doses in outpatients with acute SARS-CoV-2 infection. The ...
Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...
The U.S. Food and Drug Administration has pulled its emergency authorization for the only remaining antibody treatment currently being used for non-hospitalized individuals with mild-to-moderate COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback